- Home
- DCI vs BLDEW Comparison
DCI vs BLDEW Comparison
Compare DCI & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCI
- BLDEW
- Stock Information
- Founded
- DCI 1915
- BLDEW 2014
- Country
- DCI United States
- BLDEW United States
- Employees
- DCI N/A
- BLDEW 281
- Industry
- DCI Pollution Control Equipment
- BLDEW Transportation Services
- Sector
- DCI Industrials
- BLDEW Consumer Discretionary
- Exchange
- DCI Nasdaq
- BLDEW Nasdaq
- Market Cap
- DCI N/A
- BLDEW N/A
- IPO Year
- DCI 1987
- BLDEW N/A
- Fundamental
- Price
- DCI $68.09
- BLDEW $0.24
- Analyst Decision
- DCI Hold
- BLDEW
- Analyst Count
- DCI 4
- BLDEW 0
- Target Price
- DCI $74.00
- BLDEW N/A
- AVG Volume (30 Days)
- DCI 852.2K
- BLDEW 51.0K
- Earning Date
- DCI 02-27-2025
- BLDEW 03-13-2025
- Dividend Yield
- DCI 1.58%
- BLDEW N/A
- EPS Growth
- DCI 11.79
- BLDEW N/A
- EPS
- DCI 3.42
- BLDEW N/A
- Revenue
- DCI $3,633,400,000.00
- BLDEW $241,814,000.00
- Revenue This Year
- DCI $3.78
- BLDEW N/A
- Revenue Next Year
- DCI $4.92
- BLDEW N/A
- P/E Ratio
- DCI $19.93
- BLDEW N/A
- Revenue Growth
- DCI 4.46
- BLDEW 12.04
- 52 Week Low
- DCI $65.10
- BLDEW $0.30
- 52 Week High
- DCI $78.95
- BLDEW $0.36
- Technical
- Relative Strength Index (RSI)
- DCI 46.79
- BLDEW N/A
- Support Level
- DCI $66.46
- BLDEW N/A
- Resistance Level
- DCI $69.87
- BLDEW N/A
- Average True Range (ATR)
- DCI 1.35
- BLDEW 0.00
- MACD
- DCI -0.03
- BLDEW 0.00
- Stochastic Oscillator
- DCI 36.55
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.